Paul Brennan - University of Dundee | 人才画像

基本信息

Career Trajectory

Bio

Presently, I am working on utility of differentiated Monocyte/macrophage therapy in chronic liver disease in the translational space. I also have a broad interest in clinical hepatology including the utility of non-invasive markers of fibrosis, the pathogenesis of NAFLD including the inflammasome, and service evaluation and improvement in liver service delivery.

Research Interests

Papers共 44 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Risk Factors for Developing Barrett’s Oesophagus in Patients with Gastro-Oesophageal Reflux Disease: a Longitudinal Cohort Study

Christopher J. Byrne,Paul Brennan,James Carberry,James Cotton,John F. Dillon

BMJ OPEN GASTROENTEROLOGYno. 1 (2024)

Cited0Views0WOSBibtex

We Must Address the MASLD Awareness Gap, Improve Educational Quality and Prepare for the Digitally Quantified Self

Christopher J Kopka,Nicola Pugliese,Paul N Brennan,Jeffrey V Lazarus

Liver international official journal of the International Association for the Study of the Liverno. 9 (2024): 2099-2101

Cited0Views0WOSBibtex

Optimal ALT Threshold for the Automated Diagnosis of MASLD: A Population-Based Study Using Ilft

Jeremy Lee,Christopher J. Byrne,Paul N. Brennan,Iain MacPherson,Eleanor Dow,John F. Dillon

ANNALS OF HEPATOLOGYno. 2 (2024)

Cited0Views0WOSBibtex

Increased Risk of Chronic Kidney Disease and Mortality in a Cohort of People Diagnosed with Metabolic Dysfunction Associated Steatotic Liver Disease with Hepatic Fibrosis

Marc Gurun,Paul Brennan, Sava Handjiev, Aseil Khatib,Damien Leith,John F. Dillon,Christopher J. Byrne

PLOS ONE（2024）

Cited0Views0WOSBibtex

Progress is Impossible Without Change: Understanding the Evolving Nomenclature of Steatotic Liver Disease and Its Effect on Hepatology Practice

Paul N. Brennan,Oliver Tavabie,Wenhao Li,Thomas Marjot,Lynsey Corless,Jonathan A. Fallowfield,Helen Jarvis,Dina Mansour,Stuart Mcpherson,William Rosenberg, Karen Rockell,Jeremy Tomlinson,Andrew Yeoman,Emmanuel A. Tsochatzis,John F. Dillon,William Alazawi,Kushala W. M. Abeysekera

The Lancet Gastroenterology & hepatology (2024)

Cited0Views0WOSBibtex

Opportunities and Challenges Following Approval of Resmetirom for MASH Liver Disease

Jeffrey V. Lazarus,Dana Ivancovsky Wajcman,Henry E. Mark,Zobair M. Younossi,Christopher J. Kopka,Nevin Cohen,Meena B. Bansal, Michael Betel,Paul N. Brennan

NATURE MEDICINE (2024)

Cited0Views0WOSNATUREBibtex

A Narrative Review of Lifestyle Management Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease

Dana Ivancovsky Wajcman,Christopher J Byrne, John F Dillon,Paul N Brennan,Marcela Villota-Rivas,Zobair M Younossi,Alina M Allen, Javier Crespo,Lynn H Gerber, Jeffrey V Lazarus

Hepatology (Baltimore, Md) (2024)

Cited0Views0WOSBibtex

Beyond a Liver-Gut Focus: the Evolution of Gastroenterology and Hepatology in Challenging the Obesity and Steatotic Liver Disease Paradigm

Paul N Brennan,Shira Zelber-Sagi,Alina M Allen,John F Dillon,Jeffrey V Lazarus

Gutno. 4 (2024): 560-563

Cited0Views0WOSBibtex

Letter to the Editor: Future Proofing Transplant Hepatology Training: Shared Learnings from ‘across the Pond’

Wenhao Li,Paul N Brennan,Oliver D Tavabie

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn